Revenues from Contracts with Customers

6 Months Ended

Jun. 30, 2020

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

3.   Revenue from Contracts with Customers. We recognize revenue when a customer obtains control of promised goods. The amount of revenue recognized reflects the consideration we expect to receive in exchange for these goods. Our revenue recognition policies have not changed from those disclosed in Note 2 to our consolidated financial statements in Item 8 of the Annual Report on Form 10-K.

Disaggregation of Revenue

The disaggregation of revenue is based on reporting segment, product category and geographical region. Beginning in the first quarter of 2020, we revised our product categories to more clearly reflect how we sell our products to our customers. We presented historical information under the new revised product categories in a Current Report on Form 8-K, filed with the SEC on April 3, 2020.

We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and OEM. Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

The following tables present revenue from contracts with customers by reporting segment, product category and geographical region for the three and six-month periods ended June 30, 2020 and 2019 (in thousands):

	Three Months Ended						Three Months Ended
	June 30, 2020						June 30, 2019
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	42,614	$	30,021	$	72,635	$	55,975	$	32,873	$	88,848
Cardiac Intervention		22,698		43,307		66,005		29,145		50,498		79,643
Custom Procedural Solutions		23,383		21,936		45,319		25,150		22,066		47,216
OEM		23,607		4,611		28,218		25,843		5,116		30,959
Total		112,302		99,875		212,177		136,113		110,553		246,666
Endoscopy
Endoscopy devices		5,838		356		6,194		8,549		317		8,866
Total	$	118,140	$	100,231	$	218,371	$	144,662	$	110,870	$	255,532

	Six Months Ended						Six Months Ended
	June 30, 2020						June 30, 2019
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	98,416	$	61,294	$	159,710	$	111,575	$	61,906	$	173,481
Cardiac Intervention		51,293		87,303		138,596		56,161		96,022		152,183
Custom Procedural Solutions		48,797		44,143		92,940		48,965		44,112		93,077
OEM		47,274		9,201		56,475		49,904		8,501		58,405
Total		245,780		201,941		447,721		266,605		210,541		477,146
Endoscopy
Endoscopy devices		13,416		759		14,175		16,117		618		16,735
Total	$	259,196	$	202,700	$	461,896	$	282,722	$	211,159	$	493,881